TTS Pharma Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $341K

  • Investors
  • 4

TTS Pharma General Information

Description

Operator of cannabinoid products intended to become the leading European supplier of clean cannabinoids to the food, cosmetics, and nutraceutical markets. The company separates and purifies the various components in bulk form ready for use as an Active Pharmaceutical Ingredient (API) also works within existing legislation, enabling consumers to get quality and safe products for the ethical cannabis market.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Liverpool Science Park
  • 131 Mount Pleasant
  • Liverpool L3 5TF
  • England, United Kingdom
+44 0151
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Distributors (Healthcare)
Corporate Office
  • Liverpool Science Park
  • 131 Mount Pleasant
  • Liverpool L3 5TF
  • England, United Kingdom
+44 0151

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TTS Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 22-Oct-2021 $341K Completed Generating Revenue
6. Later Stage VC 31-Jan-2021 Completed Generating Revenue
5. Later Stage VC (Series B) 23-May-2019 Completed Generating Revenue
4. Later Stage VC 31-Jan-2019 Completed Generating Revenue
3. Early Stage VC (Series A) 01-Nov-2016 Completed Generating Revenue
2. Early Stage VC 25-Oct-2013 $620K $1.5M Completed Startup
1. Early Stage VC 26-Nov-2012 $878K $878K Completed Startup
To view TTS Pharma’s complete valuation and funding history, request access »

TTS Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
B Ordinary
A Ordinary
B Ordinary
A Ordinary
A Ordinary
B Ordinary
A Ordinary 45,178 $0.000136 $22.74 $22.74 1x $22.74 0.78%
Ordinary 133,484 $0.000136 $22.74 $22.74 1x $22.74 2.29%
To view TTS Pharma’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

TTS Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of cannabinoid products intended to become the leading European supplier of clean cannabinoids to the food, cos
Pharmaceuticals
Liverpool, United Kingdom
4 As of 2026

Las Vegas, NV
 

Vancouver, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

TTS Pharma Competitors (7)

One of TTS Pharma’s 7 competitors is GVB Biopharma, a Formerly VC-backed company based in Las Vegas, NV.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GVB Biopharma Formerly VC-backed Las Vegas, NV
Brains Bioceutical Venture Capital-Backed Vancouver, Canada
Mile High Labs Venture Capital-Backed Broomfield, CO
Aurora Biosciences Formerly VC-backed San Diego, CA
Canopy Growth Formerly Accelerator/Incubator backed Smiths Falls, Canada
You’re viewing 5 of 7 competitors. Get the full list »

TTS Pharma Patents

TTS Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4489736-A1 A cannabinoid mixture with terpenes for the treatment of anxiety Pending 08-Feb-2022
US-20250381204-A1 A cannabinoid mixture with terpenes for the treatment of anxiety Pending 08-Feb-2022
WO-2023152477-A1 A cannabinoid mixture with terpenes for the treatment of anxiety Inactive 08-Feb-2022
EP-4288038-A2 A cannabinoid mixture Pending 08-Feb-2021
GB-202101732-D0 A cannabinoid mixture Inactive 08-Feb-2021 A61K31/658
To view TTS Pharma’s complete patent history, request access »

TTS Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TTS Pharma Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Future Fund (UK) Lender/Debt Provider Minority
The North West Fund Venture Capital Minority
European Investment Bank Investment Bank Minority
Spark Impact Corporate Venture Capital Minority
To view TTS Pharma’s complete investors history, request access »

TTS Pharma Affiliates

Subsidiaries (3)

Name Industry Location Year Founded
Medisonal Group London, United Kingdom 2019
Endopure Liverpool, United Kingdom 2017
Tts Manufacturing Liverpool, United Kingdom 2017

TTS Pharma FAQs

  • When was TTS Pharma founded?

    TTS Pharma was founded in 2012.

  • Where is TTS Pharma headquartered?

    TTS Pharma is headquartered in Liverpool, United Kingdom.

  • What is the size of TTS Pharma?

    TTS Pharma has 4 total employees.

  • What industry is TTS Pharma in?

    TTS Pharma’s primary industry is Pharmaceuticals.

  • Is TTS Pharma a private or public company?

    TTS Pharma is a Private company.

  • What is the current valuation of TTS Pharma?

    The current valuation of TTS Pharma is .

  • What is TTS Pharma’s current revenue?

    The current revenue for TTS Pharma is .

  • How much funding has TTS Pharma raised over time?

    TTS Pharma has raised $31.7M.

  • Who are TTS Pharma’s investors?

    Future Fund (UK), The North West Fund, European Investment Bank, and Spark Impact have invested in TTS Pharma.

  • Who are TTS Pharma’s competitors?

    GVB Biopharma, Brains Bioceutical, Mile High Labs, Aurora Biosciences, and Canopy Growth are some of the 7 competitors of TTS Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process